Clinical Trial Update: Assessing Clinical Features and Outcome of Breast Cancer in PALB2 Mutation Carriers: the Palbreast Study

View source ↗

Summary

A clinical trial named Palbreast evaluating clinical features and outcomes of breast cancer in PALB2 mutation carriers; recruitment is ongoing in Modena, Italy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Azienda Ospedaliero-Universitaria di Modena | Conditions: Breast Cancer | Status: RECRUITING